Methylglyoxal alters glucose metabolism and increases AGEs content in C6 glioma cells

Metabolic Brain Disease

Volumn 27, Issue 4, 2012, Pages 531-539

  Hansen, Fernanda ^a   De Souza, Daniela Fraga ^a   Da Luz Silveira, Simone ^a   Hoefel, Ana Lúcia ^a   Fontoura, Júlia Bijoldo ^a   Tramontina, Ana Carolina ^a   Bobermin, Larissa Daniele ^a   Leite, Marina Concli ^a   Perry, Marcos Luiz Santos ^a   Gonçalves, Carlos Alberto ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

AGEs; C6 glioma cells; Energetic metabolism; Glyoxalase system; Methylglyoxal

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CARBON DIOXIDE; GLUCOSE; GLYCINE; HYDROXYACYLGLUTATHIONE HYDROLASE; LACTIC ACID; LACTOYLGLUTATHIONE LYASE; LIPID; METHYLGLYOXAL;

ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; GLIOMA CELL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; LACTATE BLOOD LEVEL; OXIDATION;

CELL LINE, TUMOR; COLORING AGENTS; ENERGY METABOLISM; GLIOMA; GLUCOSE; GLYCINE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LACTIC ACID; LACTOYLGLUTATHIONE LYASE; NEUTRAL RED; OXIDATION-REDUCTION; PROPIDIUM; PYRUVALDEHYDE; TETRAZOLIUM SALTS; THIAZOLES; THIOLESTER HYDROLASES;

EID: 84871405383     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-012-9329-3     Document Type: Article

References (47)

1. Abordo EA, Minhas HS, Thornalley PJ (1999) Accumulation of alphaoxoaldehydes during oxidative stress: a role in cytotoxicity. Biochem Pharmacol 58:641-648
2. Ahmed N, Battah S, Karachalias N, Babaei-Jadidi R, Horanyi M, Baroti K, Hollan S, Thornalley PJ (2003) Increased formation of methylglyoxal and protein glycation, oxidation and nitrosation in triosephosphate isomerase deficiency. Biochim Biophys Acta 1639:121-132
3. Alexander CL, Fitzgerald UF, Barnett SC (2002) Identification of growth factors that promote long-Term proliferation of olfactory ensheathing cells and modulate their antigenic phenotype. Glia 37:349-364
4. Amicarelli F, Colafarina S, Cattani F, Cimini A, Di Ilio C, Ceru MP, Miranda M (2003) Scavenging system efficiency is crucial for cell resistance to ROS-mediated methylglyoxal injury. Free Radic Biol Med 35:856-871
5. Baber Z, Haghighat N (2010) Glutamine synthetase gene expression and glutamate transporters in C6-glioma cells. Metab Brain Dis 25:413-418
6. Bouzier AK, Voisin P, Goodwin R, Canioni P, Merle M (1998) Glucose and lactate metabolism in C6 glioma cells: evidence for the preferential utilization of lactate for cell oxidative metabolism. Dev Neurosci 20:331-338
7. Dalfo E, Portero-Otin M, Ayala V, Martinez A, Pamplona R, Ferrer I (2005) Evidence of oxidative stress in the neocortex in incidental Lewy body disease. J Neuropathol Exp Neurol 64:816-830
8. Davey GE, Murmann P, Heizmann CW (2001) Intracellular Ca2+ and Zn2+ levels regulate the alternative cell density-dependent secretion of S100B in human glioblastoma cells. J Biol Chem 276:30819-30826
9. de Arriba SG, Stuchbury G, Yarin J, Burnell J, Loske C, Munch G (2007) Methylglyoxal impairs glucose metabolism and leads to energy depletion in neuronal cells-protection by carbonyl scavengers. Neurobiol Aging 28:1044-1050
10. de Souza DF, Leite MC, Quincozes-Santos A, Nardin P, Tortorelli LS, Rigo MM, Gottfried C, Leal RB, Goncalves CA (2009) S100B secretion is stimulated by IL-1beta in glial cultures and hippocampal slices of rats: Likely involvement of MAPK pathway. J Neuroimmunol 206:52-57
11. Di Loreto S, Zimmitti V, Sebastiani P, Cervelli C, Falone S, Amicarelli F (2008) Methylglyoxal causes strong weakening of detoxifying capacity and apoptotic cell death in rat hippocampal neurons. Int J Biochem Cell Biol 40:245-257
12. Dmitriev LF, Titov VN (2010) Lipid peroxidation in relation to ageing and the role of endogenous aldehydes in diabetes and other agerelated diseases. Ageing Res Rev 9:200-210
13. dos Santos Fagundes I, Rotta LN, Schweigert ID, Valle SC, de Oliveira KR, Huth Kruger A, Souza KB, Souza DO, Perry ML (2001) Glycine, serine, and leucine metabolism in different regions of rat central nervous system. Neurochem Res 26:245-249
14. Dringen R, Hamprecht B (1996) Glutathione content as an indicator for the presence of metabolic pathways of amino acids in astroglial cultures. J Neurochem 67:1375-1382
15. Dunlop DS, van EldenW, Lajtha A (1975) Optimal conditions for protein synthesis in incubated slices of rat brain. Brain Res 99:303-318
16. Freemantle E, Vandal M, Tremblay-Mercier J, Tremblay S, Blachere JC, Begin ME, Brenna JT, Windust A, Cunnane SC (2006) Omega-3 fatty acids, energy substrates, and brain function during aging. Prostaglandins Leukot Essent Fatty Acids 75:213-220
17. Fuller S, Steele M, Munch G (2010) Activated astroglia during chronic inflammation in Alzheimer's disease-do they neglect their neurosupportive roles? Mutat Res 690:40-49
18. Goldin A, Beckman JA, Schmidt AM, Creager MA (2006) Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114:597-605
19. Gundersen RY, Vaagenes P, Breivik T, Fonnum F, Opstad PK (2005) Glycine-An important neurotransmitter and cytoprotective agent. Acta Anaesthesiol Scand 49:1108-1116
20. Haghighat N, McCandless DW (1997) Effect of 6-Aminonicotinamide on metabolism of astrocytes and C6-glioma cells. Metab Brain Dis 12:29-45
21. Hertz L, Peng L, Dienel GA (2007) Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis. J Cereb Blood Flow Metab 27:219-249
22. Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J (2007) Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 30:842-847
23. Ikeda K, Higashi T, Sano H, Jinnouchi Y, Yoshida M, Araki T, Ueda S, Horiuchi S (1996) N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 35:8075-8083
24. Krautwald M, Munch G (2010) Advanced glycation end products as biomarkers and gerontotoxins -A basis to explore methylglyoxal-lowering agents for Alzheimer's disease? Exp Gerontol 45:744-751
25. Kroner Z (2009) The relationship between Alzheimer's disease and diabetes: Type 3 diabetes? Altern Med Rev 14:373-379
26. Kuhla B, Luth HJ, Haferburg D, Boeck K, Arendt T, Munch G (2005) Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease. Ann N Y Acad Sci 1043:211-216
27. Kuhla B, Luth HJ, Haferburg D, Weick M, Reichenbach A, Arendt T, Munch G (2006) Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells. J Neurosci Res 83:1591-1600
28. Kuhla B, Boeck K, Schmidt A, Ogunlade V, Arendt T, Munch G, Luth HJ (2007) Age-And stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains. Neurobiol Aging 28:29-41
29. Lapolla A, Reitano R, Seraglia R, Sartore G, Ragazzi E, Traldi P (2005) Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress. Mol Nutr Food Res 49:685-690
30. Leite MC, Galland F, de Souza DF, Guerra MC, Bobermin L, Biasibetti R, Gottfried C, Goncalves CA (2009) Gap junction inhibitors modulate S100B secretion in astrocyte cultures and acute hippocampal slices. J Neurosci Res 87:2439-2446
31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
32. Lüth HJ, Ogunlade V, Kuhla B, Kientsch-Engel R, Stahl P, Webster J, Arendt T, Munch G (2005) Age-And Stage-dependent accumulation of Advanced Glycation End Products in intracellular deposits in normal and Alzheimer's Disease brains. Cereb Cortex 15:211-220
33. Mangoura D, Sakellaridis N, Jones J, Vernadakis A (1989) Early and late passage C-6 glial cell growth: similarities with primary glial cells in culture. Neurochem Res 14:941-947
34. Mannervik B,AronssonAC,Marmstal E, Tibbelin G (1981) Glyoxalase I (rat liver). Methods Enzymol 77:297-301
35. Munch G, Taneli Y, Schraven E, Schindler U, Schinzel R, Palm D, Riederer P (1994) The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation. J Neural Transm Park Dis Dement Sect 8:193-208
36. Munch G, Thome J, Foley P, Schinzel R, Riederer P (1997) Advanced glycation endproducts in ageing and Alzheimer's disease. Brain Res Brain Res Rev 23:134-143
37. Oray B, Norton SJ (1982) Glyoxalase II from mouse liver. Methods Enzymol 90(Pt E):547-551
38. Pellerin L, Magistretti PJ (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci USA 91:10625-10629
39. + ATPase. Dev Neurosci 18:336-342
40. Phillips SA, Thornalley PJ (1993) The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. Eur J Biochem 212:101-105
41. Quincozes-Santos A, Abib RT, Leite MC, Bobermin D, Bambini-Junior V, Goncalves CA, Riesgo R, Gottfried C (2008) Effect of the atypical neuroleptic risperidone on morphology and S100B secretion in C6 astroglial lineage cells. Mol Cell Biochem 314:59-63
42. Quincozes-Santos A, Bobermin LD, Kleinkauf-Rocha J, Souza DO, Riesgo R, Goncalves CA, Gottfried C (2009) Atypical neuroleptic risperidone modulates glial functions in C6 astroglial cells. Prog Neuropsychopharmacol Biol Psychiatry 33:11-15
43. Quincozes-Santos A, Bobermin LD, Tonial RP, Bambini-Junior V, Riesgo R, Gottfried C (2010) Effects of atypical (risperidone) and typical (haloperidol) antipsychotic agents on astroglial functions. Eur Arch Psychiatry Clin Neurosci 260:475-481
44. Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM (2005) Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 15:16R-28R
45. Schmidt B, de Assis AM, Battu CE, Rieger DK, Hansen F, Sordi F, Longoni A, Hoefel AL, Farina M, Goncalves CA, Souza DO, Perry ML (2010) Effects of glyoxal or methylglyoxal on the metabolism of amino acids, lactate, glucose and acetate in the cerebral cortex of young and adult rats. Brain Res 1315:19-24
46. Tabernero A, Medina JM, Giaume C (2006) Glucose metabolism and proliferation in glia: role of astrocytic gap junctions. J Neurochem 99:1049-1061
47. Vander Jagt DL, Hunsaker LA (2003) Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase. Chem Biol Interact 144:341-351